Product NDC: | 44567-237 |
Proprietary Name: | Ceftazidime |
Non Proprietary Name: | Ceftazidime |
Active Ingredient(s): | 6 g/100mL & nbsp; Ceftazidime |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44567-237 |
Labeler Name: | WG Critical Care, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062640 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130131 |
Package NDC: | 44567-237-06 |
Package Description: | 6 VIAL in 1 CARTON (44567-237-06) > 100 mL in 1 VIAL |
NDC Code | 44567-237-06 |
Proprietary Name | Ceftazidime |
Package Description | 6 VIAL in 1 CARTON (44567-237-06) > 100 mL in 1 VIAL |
Product NDC | 44567-237 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ceftazidime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130131 |
Marketing Category Name | ANDA |
Labeler Name | WG Critical Care, LLC |
Substance Name | CEFTAZIDIME |
Strength Number | 6 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |